ROBO2 and myelodysplastic syndrome: The presence of identical mutations that were not previously involved in MDS in two different cases in which disease had progressed prompted us to validate the mutations in ROBO1 and ROBO2 in samples from additional subjects with paired samples at both lower and higher risk stages.